Delays to study start-up can undermine clinical research timelines and efficiency. All stakeholders should engage in overcoming these delays. In a new white paper, the Site-Sponsor Consortium – comprising leaders from 20 sponsors, CROs, and research sites – advocates for harmonization of Confidentiality Disclosure agreements (CDAs). These pre-negotiated agreements between a sponsor/CRO and a site/institution are an efficient solution, covering confidentiality for future feasibility activities and studies. A CDA template has been endorsed by the Site-Sponsor Consortium.
